Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing

British Journal of Cancer

Volumn 86, Issue 3, 2002, Pages 382-388

  Vassilakos, P ^a   Petignat, P ^a   Boulvain, M ^a   Campana, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Computer assisted cytology; Human papillomavirus (HPV); Liquid based cytology; Pap smear

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; CANCER SCREENING; COMPUTER SYSTEM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING TEST; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

COHORT STUDIES; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036472724     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600073     Document Type: Article

References (25)

1. A retrospective analysis of 94 patients with CIN and false negative cervical smears taken at colposcopy
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
4. HPV testing in primary screening of older women
5. Estimates of the cost impact of introducing HPV testing into a cervical screening programme
6. Federal study shows conventional Pap test remains most effective way to diagnose cervical cancer
7. Diagnostic performance of Hybrid Capture HPV-DNA assay combined with liquid-based cytologic study
8. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
9. The Papanicolaou test for cervical cancer detection: A triumph and a tragedy
10. Random rescreening of cytologic smears. A practical and effective component of quality assurance programs in both large and small cytology laboratories
11. Direct-to-vial experience with Auto-Cyte PREP in a small New England regional cytology practice
12. HPV typing and testing in gynaecological pathology: Has the time come?
13. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
14. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer
15. Toward objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types
16. Audit of deaths from cervical cancer-proposal for an essential component of the national screening program
17. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
18. Use of liquid-based cytology with HPV-DNA testing. A cost-effective approach in cervical cancer screening
19. Biopsy-based comparison of liquid-based, thin-layer preparations to conventional Pap smears
20. Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear
21. Management of suboptimal cytologic smears
22. Use of automated primary screening on liquid-based, thin-layer preparations
23. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
24. The Auto-Pap System for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice